Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Strontium Citrate.
Strontium citrate acts as a dual-action bone-seeking agent that simultaneously stimulates osteoblast-mediated bone formation and inhibits osteoclast-mediated resorption by activating the calcium-sensing receptor (CaSR).
16218641
404.39 g/mol
N/A
tetrabutylphosphanium hexafluorophosphate
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Strontium Citrate across standard consumer modalities.
The high molecular weight and density of strontium citrate require large capsule sizes to achieve therapeutic dosages, often necessitating multiple units per serving.
The high mineral load can cause significant grittiness and textural degradation of the pectin matrix, often requiring masking agents to offset a metallic aftertaste.
The high therapeutic dose required for strontium far exceeds the 20-50mg payload capacity of standard thin-film polymer matrices.
Ready to launch a product featuring Strontium Citrate? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Strontium Citrate extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Strontium Citrate payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation